JPMorgan Raises Immunovant Price Target to $47 From $35, Overweight Rating Kept
[출처/시간] MT Newswires - 2:32 PM ET, 05/26/2026 02:32 PM EDT, 05/26/2026 (MT Newswires) -- Immunovant (IMVT) has an average rating of buy and mean price target of $46.77, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us) Price: 33.81, Change: -0.
[출처/시간] MT Newswires - 2:32 PM ET, 05/26/2026
02:32 PM EDT, 05/26/2026 (MT Newswires) -- Immunovant (IMVT) has an average rating of buy and mean price target of $46.77, according to analysts polled by FactSet.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Price: 33.81, Change: -0.34, Percent Change: -1.00
당신의 반응은 무엇인가요?
좋아요
0
싫어요
0
사랑
0
재미있는
0
화난
0
슬프다
0
와우
0
